RBC Capital Downgrades Durata Therapeutics (DRTX) to Sector Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. USO
3. SPY
4. BBIO
5. NVDA
6. OPCH
7. SKYD
8. GOOGL
9. AMD
10. STZ

Go back to RBC Capital Downgrades Durata Therapeutics (DRTX) to Sector Perform

Durata Therapeutics (DRTX) to Resume Trading at 8:30AM

October 6, 2014 8:22 AM EDT

Durata Therapeutics (NASDAQ: DRTX) to Resume Trading at 8:30AM

... More

Actavis (ACT) to Acquire Durata Therapeutics (DRTX) in $675M Deal

October 6, 2014 8:01 AM EDT

Actavis (NYSE: ACT) and Durata Therapeutics, Inc. (NASDAQ: DRTX), an innovative pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses, today announced that they have entered into a definitive merger agreement under which a subsidiary of Actavis will commence a tender offer to acquire all of the outstanding shares of Durata common stock for $23.00 per share in cash, or approximately $675 million in the aggregate, and contingent value rights (CVRs) entitling the holder to receive additional cash payments of... More